切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 114 -118. doi: 10.3877/cma.j.issn.2095-3259.2014.02.009

所属专题: 文献

专家论坛

产褥期静脉血栓栓塞性疾病的诊断与处理
刘芮汐1, 漆洪波1,()   
  1. 1. 400016 重庆医科大学附属第一医院妇产科
  • 收稿日期:2014-03-09 出版日期:2014-05-18
  • 通信作者: 漆洪波

Clinical diagnosis and treatment of venous thromboembolism during the postpartum period

Ruixi Liu1, Hongbo Qi1()   

  • Received:2014-03-09 Published:2014-05-18
  • Corresponding author: Hongbo Qi
引用本文:

刘芮汐, 漆洪波. 产褥期静脉血栓栓塞性疾病的诊断与处理[J]. 中华产科急救电子杂志, 2014, 03(02): 114-118.

Ruixi Liu, Hongbo Qi. Clinical diagnosis and treatment of venous thromboembolism during the postpartum period[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(02): 114-118.

静脉血栓栓塞性疾病是产褥期妇女严重并发症之一。静脉血栓栓塞性疾病包括深静脉血栓形成及肺栓塞两种。由于该病有潜在致死性,因此早期诊断和规范治疗是改善孕产妇妊娠结局的关键。现就产褥期静脉血栓栓塞性疾病的形成机制、诊断及治疗作一阐述。

Venous thromboembolism is one of the severe complications during the postpartum period. Venous thromboembolism includes both deep venous thrombosis and pulmonary embolism. As the disease can become life-threatening, so early diagnosis and standard treatment are the keys to improve pregnancy outcomes. This paper describes the mechanism, diagnosis and treatment of puerperal venous thromboembolism.

[1]
Richter ON, Rath W. Thromboembolic diseases in pregnancy[J]. Z Geburtshilfe Neonatal, 2007, 211(1):1-7.
[2]
James AH. Prevention and management of venous thromboembolism in pregnancy[J]. Am J Med, 2007,120 (10 Suppl 2):S26-S34.
[3]
Kyrle PA, Eichinger S. Deep vein thrombosis[J]. Lancet, 2005, 365(9465):1163-1174.
[4]
James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period:incidence, risk factors, and mortality[J].Am J Obstet Gynecol, 2006, 194(5):1311-1315.
[5]
Voral S, Ghosh K, Shetty S, et al. Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western india[J].Thromb J, 2007, 5(1):9.
[6]
马水清,白春梅,盖铭英. 妊娠期及产褥期静脉血栓12例临床分析[J]. 中华妇产科杂志,1999, 34(11):649-651.
[7]
Alisa SW, Nigel M. Venous thromboembolism risk factors, biomarkers, and treatment [J]. Arterioscler Thromb Vasc Biol, 2009, 29(3):326-331.
[8]
James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period[J]. Am Obstet Gynecol, 2005, 193(1):216-219.
[9]
Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy[J]. Thromb Haemost, 2010, 103(4):718-727.
[10]
韩凤英,陈晓霞,谢倩,等. 妊娠及产褥期下肢深静脉血栓形成溶栓治疗[J]. 中国现代医学杂志,2006, 16(9):1425-1429.
[11]
Weg JG. Venous thromboembolism in pregnancy[J]. Semin Reprod Crit Care Med, 1998, 19:231-241.
[12]
Zakzouk MS. The congenital warfarin syndrome[J]. J Laryngol Otol, 1986, 100(2):215-219.
[13]
Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy[J]. Am J Med Genet, 1993, 45:17-21.
[14]
Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J]. Chest, 2004, 126(3 Suppl):188S-203S.
[15]
Spyropoulos AC, Merli G. Management of venous thromboembolism in the elderly[J]. Drugs Aging, 2006, 23(8):651-671.
[16]
Frame JN. The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiatives[J]. Seminars in Hematology, 2005, 42 (3 Suppl):28-35.
[17]
Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy[J]. Chest, 2004, 126(3 Suppl):627S-644S.
[18]
Wan S, Quinlan DJ, Agenelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials[J]. Circulation, 2004, 110:744-749.
[19]
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy:a systematic review of safety and efficacy[J]. Blood, 2005, 106(2):401-407.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[3] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[4] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[5] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[6] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[7] 张伟. 牙及牙槽外科:舒适治疗的先锋[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 386-388.
[8] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[9] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[10] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[11] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要